Annual SG&A
$0.00$12.56B-100.00%
Summary
- Current Value
- As of today, NVS annual SG&A is $0.00, down -100.00% on
- Historical Performance
- NVS annual SG&A is down -100.00% over the past 3 years, down -100.00% over the past 5 years
- All-Time High Comparison
- NVS annual SG&A is currently -100.00% below its historical high of $17.86B set on
- Sector Comparison
- NVS annual SG&A is higher than 73.06% of companies in Healthcare sector
SG&A Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Quarterly SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| TTM SG&A | $165.13B | +1150.8% | +1264.6% | +1029.0% | +799.5% | |
| Price | $156.11 | +34.4% | +49.9% | +69.9% | +183.7% | |
| Annual Operating Expenses | $24.57B | +11.4% | +20.1% | +8.2% | -7.2% | |
| Annual Operating Profit | $16.47B | +6.8% | +58.6% | +52.2% | +77.5% | |
| Annual D&A | $5.35B | -11.8% | -20.3% | +4.7% | +116.0% | |
| Annual Revenue | $54.81B | +9.0% | +29.6% | +12.0% | +9.2% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $12.56B | -100.0% | |
| 5Y | $14.89B | -100.0% | |
| All | $17.86B | -100.0% |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $0.00 | N/A | |
| 5Y | $0.00 | N/A | |
| All | $0.00 | N/A |
SG&A History
FAQ
What is the current annual SG&A of NVS?
As of today, NVS annual SG&A is $0.00
What is 1-year change in NVS annual SG&A?
NVS annual SG&A is down -100.00% year-over-year
What is 3-year change in NVS annual SG&A?
NVS annual SG&A is down -100.00% over the past 3 years
How far is NVS annual SG&A from its all-time high?
NVS annual SG&A is currently -100.00% below its historical high of $17.86B set on December 31, 2011
How does NVS annual SG&A rank versus sector peers?
NVS annual SG&A is higher than 73.06% of companies in Healthcare sector
When is NVS next annual earnings release?
As of today, the next annual earnings release for NVS has not been scheduled
SG&A Formula
SG&A = Operating Expenses − Cost Of Goods Sold − R&D
Quarterly SG&A
$0.00$3.15B-100.00%
Summary
- Current Value
- As of today, NVS quarterly SG&A is $0.00, down -100.00% on
- Historical Performance
- NVS quarterly SG&A is down -100.00% year-over-year, down -100.00% over the past 3 years
- All-Time High Comparison
- NVS quarterly SG&A is currently -100.00% below its historical high of $5.08B set on
- Sector Comparison
- NVS quarterly SG&A is higher than 46.40% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Annual SG&A | $0.00 | – | -100.0% | -100.0% | -100.0% | |
| TTM SG&A | $165.13B | +1133.3% | +1150.8% | +1264.6% | +1029.0% | |
| Price | $156.11 | +7.3% | +34.4% | +49.9% | +69.9% | |
| Quarterly Operating Expenses | $6.00B | +0.8% | -2.5% | +11.3% | +0.6% | |
| Quarterly Operating Profit | $4.74B | +26.1% | -0.4% | +75.5% | +54.1% | |
| Quarterly D&A | $1.40B | +13.6% | +18.8% | -17.9% | -3.0% | |
| Quarterly Revenue | $14.42B | +9.5% | +1.0% | +26.1% | +11.3% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $3.50B | N/A | -100.0% |
| 3Y | $3.50B | -100.0% | |
| 5Y | $3.99B | -100.0% | |
| All | $5.08B | -100.0% |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $0.00 | N/A | |
| 3Y | $0.00 | N/A | |
| 5Y | $0.00 | N/A | |
| All | $0.00 | N/A |
Quarterly SG&A History
FAQ
What is the current quarterly SG&A of NVS?
As of today, NVS quarterly SG&A is $0.00
What is NVS quarterly SG&A most recent change?
NVS quarterly SG&A was down -100.00% on June 30, 2026
What is 1-year change in NVS quarterly SG&A?
NVS quarterly SG&A is down -100.00% year-over-year
How far is NVS quarterly SG&A from its all-time high?
NVS quarterly SG&A is currently -100.00% below its historical high of $5.08B set on December 31, 2010
How does NVS quarterly SG&A rank versus sector peers?
NVS quarterly SG&A is higher than 46.40% of companies in Healthcare sector
When is NVS next earnings release?
The next earnings release for NVS is on
SG&A Formula
SG&A = Operating Expenses − Cost Of Goods Sold − R&D
TTM SG&A
$165.13B$1.88B-1.12%
Summary
- Current Value
- As of today, NVS TTM SG&A is $165.13B, down -1.12% on
- Historical Performance
- NVS TTM SG&A is up +1150.79% year-over-year, up +1264.61% over the past 3 years
- All-Time High Comparison
- NVS TTM SG&A is currently -47.68% below its historical high of $315.64B set on an earlier date
- 3-Year Low Comparison
- NVS TTM SG&A is at its 3-year low
- Sector Comparison
- NVS TTM SG&A is higher than 99.47% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM SG&A | $165.13B | +1133.3% | +1150.8% | +1264.6% | +1029.0% | |
| Annual SG&A | $0.00 | – | -100.0% | -100.0% | -100.0% | |
| Quarterly SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Price | $156.11 | +7.3% | +34.4% | +49.9% | +69.9% | |
| TTM Operating Profit | $16.21B | -0.1% | -5.5% | +44.4% | +46.0% | |
| TTM D&A | $5.65B | +4.1% | -4.6% | -20.3% | +9.4% | |
| TTM Revenue | $54.79B | +0.3% | +2.6% | +26.4% | +8.7% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $174.22B | N/A | -5.2% |
| 3Y | $239.85B | N/A | -31.1% |
| 5Y | $264.41B | N/A | -37.5% |
| All | $315.64B | N/A | -47.7% |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $165.13B | N/A | at low |
| 3Y | $165.13B | N/A | at low |
| 5Y | $165.13B | N/A | at low |
| All | $23.86B | N/A | +592.1% |
TTM SG&A History
FAQ
What is the current TTM SG&A of NVS?
As of today, NVS TTM SG&A is $165.13B
What is NVS TTM SG&A most recent change?
NVS TTM SG&A was down -1.12% on June 30, 2026
What is 1-year change in NVS TTM SG&A?
NVS TTM SG&A is up +1150.79% year-over-year
How does NVS TTM SG&A rank versus sector peers?
NVS TTM SG&A is higher than 99.47% of companies in Healthcare sector
When is NVS next earnings release?
The next earnings release for NVS is on
SG&A Formula
SG&A = Operating Expenses − Cost Of Goods Sold − R&D
Data Sources & References
- NVS Official Website www.novartis.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm
- NVS Profile on Yahoo Finance finance.yahoo.com/quote/NVS
- NVS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvs